These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15644566)

  • 1. Public response to infectious disease research: the UC Davis experience.
    Fell AH; Bailey PJ
    ILAR J; 2005; 46(1):65-71. PubMed ID: 15644566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues related to the use of animals in biocontainment research facilities.
    Copps J
    ILAR J; 2005; 46(1):34-43. PubMed ID: 15644562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Response to Radiological Releases: Have We Communicated Effectively to the First Responder Communities to Prepare Them to Safely Manage These Incidents?
    Ingram RJ
    Health Phys; 2018 Feb; 114(2):208-213. PubMed ID: 30086017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good and bad examples of siting and building biosafety level 4 laboratories: a study of Winnipeg, Galveston and Etobicoke.
    Löfstedt R
    J Hazard Mater; 2002 Jul; 93(1):47-66. PubMed ID: 12062953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication and computing technology in biocontainment laboratories using the NEIDL as a model.
    McCall J; Hardcastle K
    Pathog Dis; 2014 Jul; 71(2):96-101. PubMed ID: 24535887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Laboratory Planning: Developing Sustainable Biocontainment Laboratories in Limited Resource Areas.
    Yeh KB; Adams M; Stamper PD; Dasgupta D; Hewson R; Buck CD; Richards AL; Hay J
    Health Secur; 2016; 14(5):323-30. PubMed ID: 27559843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facility design considerations for select agent animal research.
    Frasier D; Talka J
    ILAR J; 2005; 46(1):23-33. PubMed ID: 15644561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebraska biocontainment unit design and operations.
    Lenaghan PA; Schwedhelm M
    J Nurs Adm; 2015 Jun; 45(6):298-301. PubMed ID: 26010276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
    Dickmann P; Keith K; Comer C; Abraham G; Gopal R; Marui E
    Biosecur Bioterror; 2009 Jun; 7(2):227-33. PubMed ID: 19635008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come.
    Kortepeter MG; Kwon EH; Hewlett AL; Smith PW; Cieslak TJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S137-S141. PubMed ID: 27651413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of a National Biocontainment Laboratory in Emergencies.
    Le Duc JW; Ksiazek TG
    Health Secur; 2015; 13(5):345-8. PubMed ID: 26348927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A look at a successful fee-charging urban project.
    Traitongyoo T
    JOICFP Rev; 1985 Oct; 10():32-4. PubMed ID: 12313885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication Between Infectious Disease Physicians and US State and Local Public Health Agencies: Strengths, Challenges, and Opportunities.
    Santibañez S; Polgreen PM; Beekmann SE; Cairns C; Filice GA; Layton M; Hughes JM
    Public Health Rep; 2016 Sep; 131(5):666-670. PubMed ID: 28123206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory containment practices for arthropod vectors of human and animal pathogens.
    Tabachnick WJ
    Lab Anim (NY); 2006 Mar; 35(3):28-33. PubMed ID: 16505823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing world of biocontainment and biosecurity.
    Jeggo M
    Dev Biol (Basel); 2007; 128():47-51. PubMed ID: 18084927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodefense. U.S. university backs out of biolab bid.
    Lawler A
    Science; 2005 Jul; 309(5735):682. PubMed ID: 16051758
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparedness activities and research needs in addressing emerging infectious animal and zoonotic diseases.
    Cardoen S; De Clercq K; Vanholme L; De Winter P; Thiry E; Van Huffel X
    Rev Sci Tech; 2017 Aug; 36(2):557-568. PubMed ID: 30152463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between biocontainment laboratories and their communities: a successful work in progress.
    Kanabrocki J
    Trends Microbiol; 2011 May; 19(5):209-10. PubMed ID: 21353566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.